Ephgrave Kimberly
Department of Surgery, University of Iowa Hospitals and Clinics, 200 Hawkins Drive, Iowa City IA, 52242, USA.
Surg Clin North Am. 2007 Jun;87(3):673-80. doi: 10.1016/j.suc.2007.03.003.
Extra-intestinal manifestations occur in at least 25% of Crohn's disease patients. Some extra-intestinal manifestations, such as erythema nodusum and peripheral arthropathy, will wax and wane in keeping with bowel inflammation. The more severe cutaneous ulcerations, uveitis, and axial arthropathy may precede bowel disease or persist after it subsides. Screening may be appropriate for eye disease and for osteoporosis to prevent complications. Medical management for extra-intestinal manifestations is similar to treatment for the bowel symptoms of Crohn's disease, with corticosteroids the mainstay. Pain and depression are associated with inflammatory bowel disease, and their control benefits patients. Recent small studies with anti-tumor necrosis factor (TNF) agents are promising for most extra-intestinal manifestations of Crohn's disease, and may permit more steroid-sparing disease control in the future.
至少25%的克罗恩病患者会出现肠外表现。一些肠外表现,如结节性红斑和外周关节炎,会随着肠道炎症的变化而消长。较为严重的皮肤溃疡、葡萄膜炎和中轴关节炎可能在肠道疾病之前出现,或在肠道疾病缓解后持续存在。对眼部疾病和骨质疏松症进行筛查以预防并发症可能是合适的。肠外表现的药物治疗与克罗恩病肠道症状的治疗相似,主要依靠皮质类固醇。疼痛和抑郁与炎症性肠病相关,对其进行控制对患者有益。近期针对抗肿瘤坏死因子(TNF)药物的小型研究对克罗恩病的大多数肠外表现很有前景,未来可能会实现更多减少类固醇使用的疾病控制。